Publications by authors named "Kevin A Fundora"

The gene encodes a subunit of the endosomal sorting complex required for transport (ESCRT)-I complex that is frequently lost in a wide variety of human solid cancers. We have previously demonstrated the role of VPS37A in directing the ESCRT membrane scission machinery to seal the phagophore for autophagosome completion. Here, we report that -deficient cells exhibit an accumulation of the apoptotic initiator CASP8 (caspase 8) on the phagophore and are primed to undergo rapid apoptosis through the intracellular death-inducing signaling complex (iDISC)-mediated CASP8 activation upon exposure to endoplasmic reticulum (ER) stress.

View Article and Find Full Text PDF

A composite hydrogel embedded with porous microspheres fabricated by phase separation methods was developed and showed excellent long-term anticancer drug delivery capability to cancer cells.

View Article and Find Full Text PDF

The fabrication of injectable self-cross-linkable hyperbranched poly(ε-caprolactone) (hyPCL) formulation using metal-free click chemistry was reported. The cross-linking between hyPCL32-(1R,8S,9s)-bicyclo[6.1.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Kevin A Fundora"

  • Kevin A Fundora's recent research focuses on the interplay between cellular stress responses, specifically investigating how endoplasmic reticulum (ER) stress triggers non-canonical activation of CASP8, leading to apoptosis in cancer cells.
  • He has also developed innovative drug delivery systems, including a composite hydrogel that incorporates porous microspheres for long-term, pH-sensitive delivery of anticancer drugs, highlighting advancements in targeted cancer therapies.
  • Additionally, Fundora's work explores novel materials for tissue engineering, such as an injectable platform based on poly(ε-caprolactone) dendrimers created through metal-free click chemistry, showcasing potential applications in regenerative medicine.